Trump’s Flag Map Sparks Nordic Outrage | US News

0:00It's September 8th. Welcome in. This is US News Today, where National Headlines meet AI. So, the US Food and Drug Administration, the FDA, just announced some big leadership changes. They've officially appointed new directors for two major centers, the Center for Drug Evaluation and Research, and the Center for Biologics Evaluation. And research. These are the folks who really oversee the approval process for new medicines and treatments. Michael Davis is now the permanent director for the Drug Center, and Kareem MacKyle is taking the helm at the Biologic Center. Both of them were already acting in these roles, so this is more of a confirmation of their leadership. It signals a move towards more stable management in these critical areas. Beyond those key appointments, the FDA is also bringing in new expertise. They've created a brand new position, the first-ever-devity commissioner for technology and artificial intelligence, and Jared Seahaffer is stepping into their role. This shows their series about integrating new tech into their operations.

1:03Additionally, Brett Kaplow has been named the director of the Center for Tobacco Products. This is another significant move, indicating a focus on regulating tobacco products and potentially new strategies in that department. These appointments are happening at a time when the FDA is under a lot of scrutiny and facing complex challenges. Having permanent leadership in place for these vital centers, along with a new focus on technology, could mean a shift in how they operate moving forward.